InvestLog
MREO logo

MREO

Mereo BioPharma Group plcNASDAQHealthcare
$0.32-1.19%ClosedMarket Cap: $51.1M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-23JP MorgandowngradeNeutralOverweight
2026-01-16BTIGmaintainBuyBuy
2026-01-13NeedhammaintainBuyBuy
2025-12-30JefferiesdowngradeHoldBuy
2025-12-29LifeSci CapitaldowngradeMarket PerformOutperform
2025-08-25JP MorganmaintainOverweightOverweight
2025-07-10NeedhammaintainBuyBuy
2025-05-13NeedhammaintainBuyBuy
2025-04-09NeedhammaintainBuyBuy
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.01$22.9M3
Sun Dec 31$0.05$40.3M2
Mon Dec 31$-0.05$43.6M1
Tue Dec 31$0.00$103.0M0